CLSA on Bajaj Auto: The brokerage maintained a 'buy' call on the stock with target raised to Rs 3,000 per share from Rs 2,800 earlier. It added that Q4 results were significantly better than expectations.
Nomura on Bajaj Auto: The brokerage maintains a 'buy' call on the stock with a target at Rs 3,030 per share. It expects volume recovery for Bajaj Auto in H2.
CLSA on Jubilant FoodWorks: The brokerage maintained a 'buy' on the stock with target raised to Rs 1,850 from Rs 1,800 earlier. It believes the company's credible brand positioning with a trend toward food delivery should aid its market share.
Jefferies on Dr Reddy's: The brokerage maintained 'underperform' rating on the stock but raised target price to Rs 3,000 per share from Rs 2,500 earlier. FY21 will see increased R&D and capex for Dr Reddy’s, limiting margin improvement, Jefferies says.
CLSA on Dr Reddy's: The brokerage has an 'outperform' rating on the stock with target raised to Rs 4,450 from Rs 4,250 earlier.
CLSA on UltraTech Cement: The brokerage maintained 'outperform' call on the stock with a target at Rs 3,925 per share. The company’s focus on cash conservation and debt reduction was a highlight in UltraTech’s Q4 results, CLSA said.
Morgan Stanley on Jubilant FoodWorks: The brokerage maintains 'overweight' call on the stock with a target at Rs 1,900 per share. Preparedness for new normal and cost control should drive speedy recovery for Jubilant Food going ahead, it says.
Credit Suisse on Jubilant Food: The brokerage maintains 'outperform' call on the stock with a target at Rs 1,625 per share. It cut the stock's FY21-22 earnings by 2-8 percent after Q4 earnings.
Credit Suisse on UltraTech: The brokerage maintains 'outperform' rating on the stock with target raised to Rs 4,500 per share from Rs 3,900 earlier. Overall EBITDA for the quarter-ended March largely met estimates given lower costs, it said.